Skip to main content

Table 2 Comparison of gait measures between MS and control groups in the laboratory and during daily life

From: Laboratory versus daily life gait characteristics in patients with multiple sclerosis, Parkinson’s disease, and matched controls

Gait measures Laboratory Daily Life
MS-Ctl
(N = 16)
MS
(N = 15)
Wilcox
p-value
MS-Ctl
(N = 16)
MS
(N = 15)
Wilcox
p-value
Mean SD Mean SD Mean SD Mean SD
Cadence (steps/min) 114.11  9.69 112.59  10.9 0.770 106.92 8.36 99.57 7.68 0.005
Double Support (%) 20.3  2.65 22.06 4 0.129 22.67 3.55 26.85 3.61 0.002
Elevation at Mid Swing (cm) 0.81  0.32 1.07  0.47 0.155 2.98  0.69 2.71  0.53 0.299
Gait Speed (m/s) 1.11  0.15 1  0.16 0.097 1 0.17 0.8 0.13 0.001
Foot Strike Angle (degrees) 17.97  3.34 15.65  4.68 0.188 19.38 2.64 16.25 4.16 0.037
Toe Off Angle (degrees) 36.31 3.44 31.85 3.97 0.004 27.97 3.83 23.96 4.01 0.017
Stride Duration (s) 1.06  0.09 1.08  0.11 0.767 1.17 0.1 1.25 0.1 0.017
Stride Length (m) 1.16 0.11 1.07 0.13 0.027 1.1 0.16 0.95 0.15 0.019
Swing (%) 39.84  1.34 38.91  2.1 0.123 38.81 1.85 36.58 1.85 0.002
Toe Out Angle (degrees) 9.57  4.45 11.13  6.16 0.358 17.93  8.47 18.89  11.51 0.599
Lumbar—Coronal ROM (degrees) 8.47 1.45 7.22 1.91 0.040 7.45  1.72 6.31  1.72 0.151
Lumbar—Sagittal ROM (degrees) 6.18  2.26 6.15  1.86 0.752 6.87  1.15 6.87  1.15 0.740
Lumbar—Transverse ROM (deg) 8.75  2.85 9.79  2.57 0.286 16.62  2.87 16.62  1.72 0.338
  1. Italics indicates p < 0.05, and indicates if the p-value ≤ 0.004 level of significance after Bonferroni correction (that is, 0.05/13 = 0.004)